Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Journal Mobile Options
Table of Contents
Vol. 33, No. 4, 2003
Issue release date: July – August
Section title: Original Paper
Pathophysiol Haemost Thromb 2003;33:192–196

Acquired and Inherited Thrombophilic Factors and the Risk for Residual Venous Thrombosis

Bank I.a · Tick L.W.c · Hutten B.A.b · Kramer M.H.H.c · Middeldorp S.a · Büller H.R.a
Departments of aVascular Medicine and bClinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam and cDepartment of Internal Medicine, Eemland Hospital, Amersfoort, The Netherlands
email Corresponding Author

I. Bank

Department of Vascular Medicine, Academic Medical Center

F4-277, Meibergdreef 9

NL–1105 AZ, Amsterdam (The Netherlands)

Tel. +31 20 5665976, Fax +31 20 6968833, E-Mail I.Bank@amc.uva.nl


  1. Schulman S, Svenungsson E, Granqvist S: Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am J Med 1998;104:332–338.
  2. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S: High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457–462.
  3. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA: Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 1999;78:285–291.
  4. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P: Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002;137:955–960.
  5. The Persist investigators: A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A phase II evaluation. J Thromb Haemost 2004;2:47–53.
  6. Cogo A, Lensing AW, Koopman MM, Piovella F, Siragusa S, Wells PS, Villalta S, Buller HR, Turpie AG, Prandoni P: Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: Prospective cohort study. BMJ 1998;316:17–20.
  7. Lensing AW, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, Krekt J, ten Cate JW, Huisman MV, Buller HR: Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989;320:342–345.
  8. Michiels JJ, Hamulyak K: Laboratory diagnosis of hereditary thrombophilia. Semin Thromb Hemost 1998;24:309–320.
  9. Sturk A, Morrien-Salomons WM, Huisman MV, Borm JJ, Buller HR, ten Cate JW: Analytical and clinical evaluation of commercial protein C assays. Clin Chim Acta 1987;165:263–270.
  10. Deutz-Terlouw PP, Ballering L, van Wijngaarden A, Bertina RM: Two ELISA’s for measurement of protein S, and their use in the laboratory diagnosis of protein S deficiency. Clin Chim Acta 1990;186:321–334.
  11. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol 1991;44:885–889.
  12. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–67.
  13. Danneberg J, Abbes AP, Bruggeman BM, Engel H, Gerrits J, Martens A: Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin). Clin Chem 1998;44:349–351.
  14. Ubbink JB, Hayward VW, Bissbort S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441–446.
  15. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152–155.
  16. Middeldorp S, Buller HR, Prins MH: Approach to the thrombophilic patient; in Colman RW, Hirsch JL, Marder VJ, Clowes AW, George JN (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice, ed 4. Philadelphia, Lippincott-Raven, 2000, pp 1085–1100.